Hippocratic AI has raised $126 million in its latest funding round. The healthcare-focused artificial intelligence company is now valued at $3.5 billion.
The company develops generative AI agents for the healthcare industry. These agents are designed to automate tasks and reduce the administrative burden on clinicians. Its technology helps hospitals manage shortages of nurses, social workers, and other specialists. The AI agents handle tasks like chronic care management, medication checks, and post-discharge follow-ups. This frees up healthcare professionals to focus on more critical patient needs. Hippocratic AI involves clinicians directly in the agent design process.
A prototype can be built in 30 minutes and tested within a few hours after undergoing extensive safety training.
In 15 months, the company has partnered with over 50 health systems. Its agents have completed more than 115 million patient interactions with no reported safety issues.
The Series C round was led by Avenir Growth. It also saw participation from notable investors like CapitalG, General Catalyst, and Andreessen Horowitz.
Hippocratic AI will use the new capital to fuel product development and global expansion.
